N/A
N=206
Remote Surveillance of Postpartum Hypertension
Hypertension in Pregnancy
Bottom Line
View on ClinicalTrials.gov: NCT03185455 ↗Enrolled (actual)
206
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Number of Participants Whose Blood Pressure Was Assessed in the First Ten Days Following Discharge — 45; 95 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Remote (text based) surveillance (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Pennsylvania
- Primary completion
- Jan 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Whose Blood Pressure Was Assessed in the First Ten Days Following Discharge |
45; 95 | — |
| SECONDARY Number of Participants Who Required Antihypertensive Medication Initiation or Dose Adjustment Within 2 Weeks Postpartum |
10; 17 | — |
| SECONDARY Number of Participants Who Required Additional ER or Office Visits for Hypertension (Not Resulting in Readmission) Within 2 Weeks Postpartum |
2; 3 | — |
| SECONDARY Number of Participants With Hypertension Related Readmission Within 2 Weeks Postpartum |
4; 0 | — |
| SECONDARY Patient Satisfaction |
0; 77 | — |
Summary
Women with hypertensive disorders of pregnancy need postpartum blood pressure (BP) surveillance to detect persistent hypertension. Various barriers result in only 30% attendance at postpartum BP visits. A more effective strategy is needed. Women with hypertension of pregnancy will be randomized to either text-based monitoring or office visits. Those randomized to the intervention will receive a BP cuff and text in their BP to an automated, clinician derived, HIPAA compliant text-based algorithm.
Eligibility Criteria
Inclusion Criteria
- Women with chronic hypertension, gestational hypertension, or preeclampsia who deliver at the Hospital of the University of Pennsylvania will be eligible to participate. All patients must be > 18 years old, able to speak and read English, have a hypertension diagnosis, and have access to a cell phone with unlimited text message capabilities.
Exclusion Criteria
- Women without access to a cell phone with unlimited text message capabilities will be excluded from the study in order to eliminate barriers to participate in remote surveillance. However, we will track the number of women not eligible for this reason in order to understand generalizability in an urban population.
Data sourced from ClinicalTrials.gov (NCT03185455). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.